Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,456Revenue $M1,351Net Margin (%)12.8Altman Z-Score8.9
Enterprise Value $M7,048EPS $3.2Operating Margin %22.4Piotroski F-Score8
P/E(ttm)129Beneish M-Score-3.6Pre-tax Margin (%)21.5Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales6.45-y EBITDA Growth Rate %55.8Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow18.6y-y EBITDA Growth Rate %-27.2ROA % (ttm)9.1Higher Current Ratio y-yY
Dividend Yield %--PEG2.3ROE % (ttm)15.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.5ROIC % (ttm)25.8Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 163.737%Reduce 9.91%291,077
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 163.737%Add 3.44%372,580
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 163.737%New holding2,450
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 163.7327%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 163.7359%Reduce 55.36%288,401
UTHRFirst Eagle Investment 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 163.7359%New holding262,080
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 163.7370%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 163.7359%Add 62.64%316,489
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 163.7382%Reduce 47.71%194,595
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 163.73124%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 163.73124%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 163.73154%Add 15.34%341,330
UTHRJoel Greenblatt 2013-03-31 Add0.02%$51.64 - $62.57
($56.61)
$ 163.73189%Add 2.24%295,921
UTHRVanguard Health Care Fund 2013-03-31 Reduce-0.02%$51.64 - $62.57
($56.61)
$ 163.73189%Reduce 11.23%1,320,000
UTHRDavid Dreman 2013-03-31 Reduce$51.64 - $62.57
($56.61)
$ 163.73189%Reduce 2.46%55,625
UTHRHOTCHKIS & WILEY 2012-12-31 Sold Out -0.09%$44.99 - $58.91
($52.11)
$ 163.73214%Sold Out0
UTHRDavid Dreman 2012-12-31 Buy 0.09%$44.99 - $58.91
($52.11)
$ 163.73214%New holding57,025
UTHRJoel Greenblatt 2012-12-31 Add0.03%$44.992 - $58.91
($52.13)
$ 163.73214%Add 3.34%289,442
UTHRVanguard Health Care Fund 2012-12-31 Reduce-0.03%$44.992 - $58.91
($52.13)
$ 163.73214%Reduce 6.30%1,487,000
UTHRJoel Greenblatt 2012-09-30 Reduce-0.19%$49.87 - $58.3
($54.58)
$ 163.73200%Reduce 15.82%280,089
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & Co-CEO 2015-08-03Sell2,592$164.84-0.67view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-30Sell4,115$161.141.61view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-30Sell5,547$161.671.27view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-29Sell2,211$166.18-1.47view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-27Sell2,592$166.38-1.59view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-23Sell5,547$175.73-6.83view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-23Sell4,115$176.38-7.17view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-22Sell2,211$174.55-6.2view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-20Sell2,592$177.92-7.98view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-07-16Sell9,662$175.51-6.71view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
John Hussman's Third Quarter Top 5 Nov 07 2013 
Vanguard Health Care Fund Selling Update Oct 30 2013 
comment on UTHR May 11 2013 
Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 
comment on UTHR Mar 23 2013 

More From Other Websites
UNITED THERAPEUTICS CORP Financials Jul 31 2015
United Therapeutics Misses on Q2 Earnings & Revenues - Analyst Blog Jul 29 2015
United Therapeutics (UTHR) Earnings Report: Q2 2015 Conference Call Transcript Jul 28 2015
4 IBD 50 Stocks Poised To Bounce Back With Market Jul 28 2015
Edited Transcript of UTHR earnings conference call or presentation 28-Jul-15 1:00pm GMT Jul 28 2015
5 Health Care Stocks to Trade for Gains -- Must-See Charts Jul 28 2015
United Therapeutics Plunges On Q2 Sales Miss Jul 28 2015
Q2 2015 United Therapeutics Corp Earnings Release - Before Market Open Jul 28 2015
United Therapeutics Corporation Reports Second Quarter 2015 Financial Results Jul 28 2015
United Therapeutics beats 2Q profit forecasts Jul 28 2015
United Therapeutics beats 2Q profit forecasts Jul 28 2015
UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 28 2015
UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report Jul 28 2015
United Therapeutics Corporation Reports Second Quarter 2015 Financial Results Jul 28 2015
United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open... Jul 22 2015
United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open... Jul 22 2015
Why This Analyst Expects New Alzhemier’s Trials Could Produce the Most Important Drugs in History Jul 21 2015
Mayo Clinic and United Therapeutics Collaborate on Lung Restoration Center Jul 13 2015
Why Jazz Pharmaceuticals Is Winning Jun 29 2015
Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors Jun 29 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK